10 Best Low Priced Stocks to Get Rich in 2026
These days, everyone is focusing on finding ways to get rich. The real catch is when this opportunity comes at a low price.
Avalo Therapeutics Inc. (AVTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Caligan Partners David Johnson | 1,635,023 | $24,410,893 | +86% | 1.62% |
| 2. | Biotechnology Value Fund / BVF Inc Mark Lampert | 1,632,845 | $24,378,376 | +21% | 0.78% |
| 3. | VenBio Select Advisor Kurt Von Emster | 1,410,000 | $21,051,300 | 0.21% | |
| 4. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,235,000 | $18,438,550 | 0.68% | |
| 5. | 1,000,000 | $14,930,000 | 0.75% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.00 | 500 | $6,500.00 | 1,000 | 2024-11-13 | Filing | |
| $12.50 | 500 | $6,249.50 | 500 | 2024-11-12 | Filing | |
| $0.62 | 182,300 | $113,026.00 | 0 | 2023-06-26 | Filing | |
| $0.64 | 1,425,700 | $917,152.81 | 0 | 2023-06-26 | Filing | |
| $4.14 | 2,000 | $8,288.80 | 1,425,700 | 2023-06-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 4,654 | $93,080.00 | 51,776 | 2026-06-30 | Filing | |
| $18.00 | 1,450 | $26,100.00 | 51,776 | 2026-06-23 | Filing | |
| $16.00 | 679 | $10,864.00 | 47,122 | 2026-05-28 | Filing | |
| $18.76 | 3,000 | $56,280.00 | 3,622 | 2026-05-15 | Filing | |
| $24.12 | 18,606 | $448,817.65 | 423 | 2026-05-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,879,481 | $42,990,651 | 0% | |
| 2. | 1,340,840 | $20,018,741 | 1.03% | |
| 3. | 1,141,980 | $17,049,761 | 0% | |
| 4. | 856,962 | $12,794,443 | 0.13% | |
| 5. | 738,383 | $11,024,058 | 0.32% |
News See All
Piper Sandler Maintains Bullish $48 Price Target on Avalo Therapeutics (AVTX)
Avalo Therapeutics, Inc. (NASDAQ:AVTX) is one of the top long-term biotechnology stocks to buy. On October 17, Piper Sandler analyst Yasmeen Rahimi reaffirmed her Buy rating on Avalo Therapeutics Inc.
Top 8 Long-Term Biotechnology Stocks to Buy
Momentum in biotechnology stocks is accelerating after years of underperformance.
Avalo Adds Dr. Rita Jain to Board as LOTUS Trial Advances
Avalo Therapeutics, Inc. (NASDAQ:AVTX) is among the best growth stocks to invest in for the next 5 years. On Monday, the management of Avalo Therapeutics, Inc.
15 Best Growth Stocks to Invest in for the Next 5 Years
Before making any decision, whether big or small, we instinctively weigh its long-term impact, and this is particularly true in the case of stocks.
5 Hot Healthcare Stocks To Buy Now
In this article, we will be taking a look at 5 hot healthcare stocks to buy now.
Hedge Fund Resource Center